Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BIOCARDIA INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
1
0
0
No Price
29.04.2026 15:50
Current Prices from BIOCARDIA INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
BCDA
USD
29.04.2026 15:50
1,12 USD
-0,02 USD
-2,19 %
IEX
BCDA
USD
29.04.2026 15:06
1,13 USD
-0,01 USD
-0,88 %
Share Float & Liquidity
Free Float71,68 %
Shares Float4,16 M
Shares Outstanding5,8 M
Company Profile for BIOCARDIA INC Share
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
